Senores Pharmaceuticals Limited (BOM:544319)

Market Cap	41.41B +71.9%
Revenue (ttm)	5.53B +43.2%
Net Income	1.02B +79.3%
EPS	22.43 +40.3%
Shares Out	n/a
PE Ratio	40.76
Forward PE	31.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,302
Average Volume	13,665
Open	918.95
Previous Close	900.15
Day's Range	892.20 - 918.95
52-Week Range	474.00 - 950.00
Beta	n/a
RSI	61.11
Earnings Date	May 30, 2026

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supp...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 194
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544319

Financial Performance

In fiscal year 2025, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.